In today’s briefing:
- STAR50 Jun 2026 Index Rebalance: Post-Implementation Review
- CSI 300 June 2026 Rebalance: Post-Implementation Review
- CXMT Corporation (688825 CH) IPO: Valuation Insight
- IPO Databook: Hangzhou BOCO Electronics (HK) – Jul 2026
- Alibaba (BABA US / 9988 HK): Cloud Inflection, Discounted for Geopolitics
- Genfleet Therapeutics (2595 HK) Placement: RAS Portfolio Offerings To Deliver Strength
- Aequitas: New Hope Dairy A/H Listing – Topline Rebounded, But Industry Is Highly Competitive
- Primer: Eastern Communications (600776 CH) – Jul 2026
- Pre-IPO Verisilicon Microelectronics (A/H Listing)-Difficulty Breaking Through Competitors’ Barriers
STAR50 Jun 2026 Index Rebalance: Post-Implementation Review
- CSI added four stocks and deleted four in the Jun 2026 STAR50 rebalance. The first implementation week and weeks 2 to 4 are complete.
- Every ADD rose through the first implementation week, vs the historical fade, and most of the cohort kept the gain through weeks 2 to 4.
- Most DELETEs fell in the first week, in line with history. SICC rallied vs its negative-bridge base rate before a reversal in weeks 2 to 4.
CSI 300 June 2026 Rebalance: Post-Implementation Review
- CSI 300 June 2026 added 19 stocks and deleted 19. With all post-implementation windows complete, we review current-cycle performance vs history.
- ADDs rose broadly in the first implementation week. The historical fade read was offset by a stronger CSI 300 tape and tungsten-specific newsflow. Weeks 2 to 4 reversed the gains.
- DELETEs fell in the first week and drifted lower in weeks 2 to 4. The direction matched history, and the losses were milder than in prior cycles.
CXMT Corporation (688825 CH) IPO: Valuation Insight
- CXMT Corporation (688825 CH) concluded its IPO price at Rmb8.66, and we estimate this equals 5x PER for FY26 and 3.4x for FY27.
- It is inexpensive relative to global peers, as they are trading at an average of 8.1x and 6.1x, respectively. Normally, A-shares trade at a higher multiple than global peers.
- Applying the Hang Seng AH premium on the IPO, there is a 74.5% upside. Aggressively, if GPU companies are used as references, it may even provide a 3x upside.
IPO Databook: Hangzhou BOCO Electronics (HK) – Jul 2026
- Hangzhou BOCO Electronics is the second largest provider of high-performance computing server power supply in Chinese mainland by 2025 revenue, also expanding into ESS Power Conversion.
- BOCO is the second largest Chinese mainland high-performance computing server power supply provider with 15.8% market share in 2025, seeing revenue and profit growth.
- Revenue reached RMB1,044,596 and profit RMB97,131 in 2025, but Q1 2026 saw a RMB(5,324) loss and (2.5)% net profit margin.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.
Alibaba (BABA US / 9988 HK): Cloud Inflection, Discounted for Geopolitics
- Cloud Intelligence AI revenue has posted 11 straight quarters of triple-digit growth; four banks cut targets in July but kept Buy-equivalent ratings.
- DOJ settlement resolved, Qwen approved for Apple Intelligence in China — geopolitical overhangs are clearing faster than consensus assumes.
- SOTP-Derived TP of US$170/ADS (44% upside) & CNY151.9 (65% upside) applies an explicit 10% discount for unresolved geopolitical risk that most sell-side models don’t itemise.
Genfleet Therapeutics (2595 HK) Placement: RAS Portfolio Offerings To Deliver Strength
- Genfleet Therapeutics (2595 HK) announced the placement of 13.6M shares for subscription at HK$ 34.69 per share. The placing price represents a discount of 9.7% to the undisturbed price.
- Genfleet Therapeutics intends to use the proceeds majorly to advance core products of RAS inhibitors and other innovative treatments, enhance company’s research and development platforms and for working capital.
- Genfleet is rightly placed at this point to accelerate the clinical development of core products, rapidly advance their innovative product pipeline to later stages of development and expand the portfolio.
Aequitas: New Hope Dairy A/H Listing – Topline Rebounded, But Industry Is Highly Competitive
- New Hope Dairy Co Ltd (002946 CH), a nutritional food company specializing in dairy products, aims to raise around US$100m in its H-share listing.
- New Hope Dairy (NHD) is a technology-driven nutritional food company dedicated to the R&D and production of dairy products and other nutritional foods.
- In this note, we talk about the company’s past performances.
Primer: Eastern Communications (600776 CH) – Jul 2026
- Eastern Communications is a diversified technology company with a significant presence in China’s telecommunications and financial technology sectors. The company is well-positioned to benefit from the country’s ongoing 5G network expansion and digital transformation initiatives.
- Despite a recent history of declining revenues, the company has demonstrated impressive growth in net income and earnings per share, suggesting successful cost management and a shift towards higher-margin businesses.
- The stock’s valuation appears attractive on a price-to-book basis compared to peers, but its high price-to-earnings ratio and the competitive nature of the Chinese telecom market present notable risks for investors.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.
Pre-IPO Verisilicon Microelectronics (A/H Listing)-Difficulty Breaking Through Competitors’ Barriers
- VeriSilicon is a rare company in the world that can provide a complete IP portfolio and one-stop services from design to production, and has a faster response to regional services.
- The challenge is the ecological barriers of ARM and Synopsys is extremely deep, making it difficult to form substantive competition in the field of general-purpose processor IP in short term
- Considering the differences in liquidity between SSE Star Market and HK stock market, a discount of approximately 30%-40% is more comfortable, which may leave enough “margin of safety” for investors.

